
Derek Cothran, M.H.A., Senior Director, provides strategic direction to multiple clients for their specialty medications across a range of disease states. This includes the design and implementation of reimbursement support programs as well as programs for the uninsured and underinsured. He works closely with other AmerisourceBergen Specialty Group companies to integrate these programs across other identified needs such as adherence, specialty distribution and strategic consulting.
In addition, Mr. Cothran actively engages with manufacturers to respond to regulatory requirements such as Risk Evaluation and Mitigation Strategies (REMS) that impact product commercialization. In this role he has partnered with manufacturers to determine the appropriate services that are required for patients and providers to access therapy while adhering to the agreed-upon risk management plan.
He has also been a speaker regarding patient access issues, industry support service trends, reimbursement landscape changes and REMS.
Before joining Lash Group, Mr. Cothran worked at a healthcare accounting and consulting firm where he provided strategy and financial services to hospitals, health systems, physicians, and long-term care facilities. He specialized in service line and business plan development as well as long-term competitive strategies. Mr. Cothran received an M.H.A. and a B.S. in physiology from the University of South Carolina.
« Back
